Abstract
Head and neck cancer is a general term for tumors that have multiple origins and various histological types. The chemotherapy regimen varies depending on the histological type, and a different treatment strategy is sometimes required by site of occurrence even if the histological type is the same. This paper discusses the transition and future perspective of treatment development for various head and neck cancers, including the utility and problems of comprehensive gene analysis.